96 related articles for article (PubMed ID: 2649014)
1. Risk assessment of PUVA and cyclosporine. Lessons from the past; challenges for the future.
Stern RS
Arch Dermatol; 1989 Apr; 125(4):545-7. PubMed ID: 2649014
[No Abstract] [Full Text] [Related]
2. Risk of skin tumors in psoralen- and ultraviolet A-treated patients.
Henseler T; Christophers E
Natl Cancer Inst Monogr; 1984 Dec; 66():217-9. PubMed ID: 6531033
[TBL] [Abstract][Full Text] [Related]
3. [Psoriasis, skin cancer and PUVA].
Derm Beruf Umwelt; 1981; 29(2):46-7. PubMed ID: 7238301
[No Abstract] [Full Text] [Related]
4. [Treatment of psoriasis and skin cancer. Risk of skin cancer is affected by DNA repair capacity].
Vogel U; Dybdahl M; Wallin H; Nexø BA
Ugeskr Laeger; 2000 Dec; 162(50):6861. PubMed ID: 11187147
[No Abstract] [Full Text] [Related]
5. Re-PUVA.
Lassus A
Photodermatol; 1984 Dec; 1(6):263-4. PubMed ID: 6533618
[No Abstract] [Full Text] [Related]
6. Review of cyclosporine immunosuppressive safety data in dermatology patients after two decades of use.
Behnam SM; Behnam SE; Koo JY
J Drugs Dermatol; 2005; 4(2):189-94. PubMed ID: 15776776
[TBL] [Abstract][Full Text] [Related]
7. Should PUVA be abandoned?
Wolff K
N Engl J Med; 1997 Apr; 336(15):1090-1. PubMed ID: 9091807
[No Abstract] [Full Text] [Related]
8. Systemic treatment of severe psoriasis--the role of cyclosporine.
Lowe NJ
N Engl J Med; 1991 Jan; 324(5):333-4. PubMed ID: 1986292
[No Abstract] [Full Text] [Related]
9. [Photochemotherapy (PUVA): pro and con].
Wolff K
Hautarzt; 1985 Jan; 36(1):25-33. PubMed ID: 3918959
[TBL] [Abstract][Full Text] [Related]
10. The risk of melanoma in association with long-term exposure to PUVA.
Stern RS;
J Am Acad Dermatol; 2001 May; 44(5):755-61. PubMed ID: 11312420
[TBL] [Abstract][Full Text] [Related]
11. Multiple eruptive actinic keratoses and squamous cell carcinomata following PUVA therapy of more than 11 years.
Beiteke U; Budde J; Lentner A; Stary A; Tronnier H
Photodermatol; 1988 Dec; 5(6):274-6. PubMed ID: 3249686
[No Abstract] [Full Text] [Related]
12. [Photochemotherapy and skin cancer. The occurrence of premalignant and malignant skin changes in patients with psoriasis treated with photochemotherapy (PUVA therapy)].
Mørk NJ; Braathen LR; Rajka G; Hoel PS
Tidsskr Nor Laegeforen; 1988 Mar; 108(8-9):676-8. PubMed ID: 3353970
[No Abstract] [Full Text] [Related]
13. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients.
Berne B; Fischer T; Michaëlsson G; Norén P
Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278
[TBL] [Abstract][Full Text] [Related]
14. PUVA carcinogenesis after ten years: prospect and retrospect.
Stern RS
Photodermatol; 1986 Oct; 3(5):257-60. PubMed ID: 3822870
[No Abstract] [Full Text] [Related]
15. Consensus workshop on the toxic effects of long-term PUVA therapy.
Morison WL; Baughman RD; Day RM; Forbes PD; Hoenigsmann H; Krueger GG; Lebwohl M; Lew R; Naldi L; Parrish JA; Piepkorn M; Stern RS; Weinstein GD; Whitmore SE
Arch Dermatol; 1998 May; 134(5):595-8. PubMed ID: 9606329
[TBL] [Abstract][Full Text] [Related]
16. Psoriasis and cancer.
Halprin KM
J Am Acad Dermatol; 1984 Jan; 10(1):117-9. PubMed ID: 6693590
[No Abstract] [Full Text] [Related]
17. [PUVA therapy and skin cancer].
Lassus A; Reunala T; Idänpään-Heikkilä J; Juvakoski T; Salo O
Duodecim; 1981; 97(4):185-90. PubMed ID: 7238374
[No Abstract] [Full Text] [Related]
18. Treating psoriasis.
Dover J
Health News; 1998 Oct; 4(13):3, 5. PubMed ID: 9803171
[No Abstract] [Full Text] [Related]
19. Mutagenicity and carcinogenicity of methoxsalen plus UV-A.
Roelandts R
Arch Dermatol; 1984 May; 120(5):662-9. PubMed ID: 6372701
[TBL] [Abstract][Full Text] [Related]
20. PUVA at the Skin and Cancer Foundation (Melbourne) 1987-1993.
Sinclair RD; Fergin P; Lane P
Australas J Dermatol; 1994; 35(1):42. PubMed ID: 7998899
[No Abstract] [Full Text] [Related]
[Next] [New Search]
